211 related articles for article (PubMed ID: 19417567)
1. Preactive lesions in multiple sclerosis.
van der Valk P; Amor S
Curr Opin Neurol; 2009 Jun; 22(3):207-13. PubMed ID: 19417567
[TBL] [Abstract][Full Text] [Related]
2. Alphab-crystallin is a target for adaptive immune responses and a trigger of innate responses in preactive multiple sclerosis lesions.
van Noort JM; Bsibsi M; Gerritsen WH; van der Valk P; Bajramovic JJ; Steinman L; Amor S
J Neuropathol Exp Neurol; 2010 Jul; 69(7):694-703. PubMed ID: 20535035
[TBL] [Abstract][Full Text] [Related]
3. Clusters of activated microglia in normal-appearing white matter show signs of innate immune activation.
van Horssen J; Singh S; van der Pol S; Kipp M; Lim JL; Peferoen L; Gerritsen W; Kooi EJ; Witte ME; Geurts JJ; de Vries HE; Peferoen-Baert R; van den Elsen PJ; van der Valk P; Amor S
J Neuroinflammation; 2012 Jul; 9():156. PubMed ID: 22747960
[TBL] [Abstract][Full Text] [Related]
4. Preactive multiple sclerosis lesions offer novel clues for neuroprotective therapeutic strategies.
van Noort JM; van den Elsen PJ; van Horssen J; Geurts JJ; van der Valk P; Amor S
CNS Neurol Disord Drug Targets; 2011 Feb; 10(1):68-81. PubMed ID: 21143143
[TBL] [Abstract][Full Text] [Related]
5. Blood-brain barrier alterations in both focal and diffuse abnormalities on postmortem MRI in multiple sclerosis.
Vos CM; Geurts JJ; Montagne L; van Haastert ES; Bö L; van der Valk P; Barkhof F; de Vries HE
Neurobiol Dis; 2005 Dec; 20(3):953-60. PubMed ID: 16039866
[TBL] [Abstract][Full Text] [Related]
6. Homogeneity of active demyelinating lesions in established multiple sclerosis.
Breij EC; Brink BP; Veerhuis R; van den Berg C; Vloet R; Yan R; Dijkstra CD; van der Valk P; Bö L
Ann Neurol; 2008 Jan; 63(1):16-25. PubMed ID: 18232012
[TBL] [Abstract][Full Text] [Related]
7. Alpha-B-crystallin induces an immune-regulatory and antiviral microglial response in preactive multiple sclerosis lesions.
Bsibsi M; Holtman IR; Gerritsen WH; Eggen BJ; Boddeke E; van der Valk P; van Noort JM; Amor S
J Neuropathol Exp Neurol; 2013 Oct; 72(10):970-9. PubMed ID: 24042199
[TBL] [Abstract][Full Text] [Related]
8. The pathologic substrate of magnetic resonance alterations in multiple sclerosis.
Lassmann H
Neuroimaging Clin N Am; 2008 Nov; 18(4):563-76, ix. PubMed ID: 19068402
[TBL] [Abstract][Full Text] [Related]
9. Hypoperfusion of the cerebral white matter in multiple sclerosis: possible mechanisms and pathophysiological significance.
De Keyser J; Steen C; Mostert JP; Koch MW
J Cereb Blood Flow Metab; 2008 Oct; 28(10):1645-51. PubMed ID: 18594554
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of distinct galectins in multiple sclerosis lesions.
Stancic M; van Horssen J; Thijssen VL; Gabius HJ; van der Valk P; Hoekstra D; Baron W
Neuropathol Appl Neurobiol; 2011 Oct; 37(6):654-71. PubMed ID: 21501208
[TBL] [Abstract][Full Text] [Related]
11. Microglial nodules in early multiple sclerosis white matter are associated with degenerating axons.
Singh S; Metz I; Amor S; van der Valk P; Stadelmann C; Brück W
Acta Neuropathol; 2013 Apr; 125(4):595-608. PubMed ID: 23354834
[TBL] [Abstract][Full Text] [Related]
12. Influence of neurosteroids on the pathogenesis of multiple sclerosis.
Leitner H
Med Hypotheses; 2010 Aug; 75(2):229-34. PubMed ID: 20227191
[TBL] [Abstract][Full Text] [Related]
13. Cortical pathology in multiple sclerosis.
Stadelmann C; Albert M; Wegner C; Brück W
Curr Opin Neurol; 2008 Jun; 21(3):229-34. PubMed ID: 18451703
[TBL] [Abstract][Full Text] [Related]
14. Progranulin expression in brain tissue and cerebrospinal fluid levels in multiple sclerosis.
Vercellino M; Grifoni S; Romagnolo A; Masera S; Mattioda A; Trebini C; Chiavazza C; Caligiana L; Capello E; Mancardi GL; Giobbe D; Mutani R; Giordana MT; Cavalla P
Mult Scler; 2011 Oct; 17(10):1194-201. PubMed ID: 21613335
[TBL] [Abstract][Full Text] [Related]
15. Review: the architecture of inflammatory demyelinating lesions: implications for studies on pathogenesis.
Lassmann H
Neuropathol Appl Neurobiol; 2011 Dec; 37(7):698-710. PubMed ID: 21696413
[TBL] [Abstract][Full Text] [Related]
16. Oligodendrocytes and the early multiple sclerosis lesion.
Prineas JW; Parratt JD
Ann Neurol; 2012 Jul; 72(1):18-31. PubMed ID: 22829266
[TBL] [Abstract][Full Text] [Related]
17. Gray and normal-appearing white matter in multiple sclerosis: an MRI perspective.
Vrenken H; Geurts JJ
Expert Rev Neurother; 2007 Mar; 7(3):271-9. PubMed ID: 17341175
[TBL] [Abstract][Full Text] [Related]
18. Pathological abnormalities in the normal-appearing white matter in multiple sclerosis.
Allen IV; McQuaid S; Mirakhur M; Nevin G
Neurol Sci; 2001 Apr; 22(2):141-4. PubMed ID: 11603615
[TBL] [Abstract][Full Text] [Related]
19. Voxel-based analysis of the evolution of magnetization transfer ratio to quantify remyelination and demyelination with histopathological validation in a multiple sclerosis lesion.
Chen JT; Kuhlmann T; Jansen GH; Collins DL; Atkins HL; Freedman MS; O'Connor PW; Arnold DL;
Neuroimage; 2007 Jul; 36(4):1152-8. PubMed ID: 17543541
[TBL] [Abstract][Full Text] [Related]
20. Microglia in normal appearing white matter of multiple sclerosis are alerted but immunosuppressed.
Melief J; Schuurman KG; van de Garde MD; Smolders J; van Eijk M; Hamann J; Huitinga I
Glia; 2013 Nov; 61(11):1848-61. PubMed ID: 24014207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
